Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Global Bioinformatics Market (Sectors, Product & Services, Applications, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
Published: May-2014    |    Formats: PDF & Excel   |   Author(s):Debbie Shields   |   Code: DI 14136
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology
  • Analyst's
    Review
  • Sample

Pages 151
Tables 48

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc. 

The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives. The factor limiting this market is the need for skilled personnel due to the complexity of the bioinformatics tools used. The other limiting factors are the saturation of the pharmaceutical sectors and lack of common data formats. The factors that would provide opportunity for the growth of this market are standardization of databases, need for integration systems and solutions and need to control data overload due to the piling-up of data due to the numerous experiments conducted. The reason to study this market is to understand the current trends and applications in the bioinformatics field along with in depth analysis of the segments.

Bioinformatics Technology and Services Market Analysis

The bioinformatics technology and services market is segmented into knowledge management tools, bioinformatics platforms and bioinformatics services. The Bioinformatics platform market was the highest revenue generating market in 2013. This was due to the increased application usage of the platforms in various genomic applications. However, the Knowledge Management Tools is expected to emerge as the highest revenue generating segment by 2020 due to the increasing number of data generated due to the increasing clinical trials.

Bioinformatics Application Market Analysis

The bioinformatics application market is segmented based on, metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics and others. The Genomics was the highest revenue generating market among the bioinformatics application market in 2013. This was due to the increased applications in drug discovery and development using bioinformatics tools. The tools proved to be cost and time efficient for the pharmaceutical companies. The Chemoinformatics and Drug Design is expected to be the highest revenue generating segment by 2020 due to its ability to use information in the selection and designing of the drug cycle. 

Bioinformatics Sector Market Analysis

The bioinformatics sector is segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics and others. The Medical bioinformatics was and is forecast to be the highest revenue generating market through 2020. This was due to the increasing application of drug discovery and development using bioinformatics tools, which were also used in the preventive medicine and gene therapy. 

Bioinformatics Geographic Market Analysis

The geography segment is segmented into North America, Europe, Asia Pacific and RoW. North America was the highest revenue generating region in 2013 due to the wider adoption of advanced technology in the region. North America was followed by Europe  as the second largest revenue generating segment in 2013 due to the continuous adoption of new technology in the field of drug discovery and development. The market scenario for bioinformatics is expected to remain same throughout the forecast period.

Competitive Landscape

The key companies profiled in this report are Accelrys, Inc., Affymetrix, Inc., Agilent Technologies, Inc., Geneva bioinformatics, Non linear dynamics, Quest Diagnostics, Inc., Life Technologies corp., Illumina, Bruker Daltonics, Inc., and Biomax Informatics AG. The key strategies opted by the market players are Product Launch, Agreement and Collaboration. 

High Level Analysis

The market analysis is done based on Porter’s five forces model and Value chain analysis. According to the Porter’s five forces model the bargaining power of the supplier’s is low due to the presence of many bioinformatics service providers and the threat from internal substitutes of this market is moderate. According to the value chain analysis the major revenue is generated from the drug discovery segment. In the past, the R&D activity in the biotechnology and pharmaceutical industry had a restrictive budget. However, due to the advancement in the IT solutions, the cost involved in the R&D activity has become cost and time efficient. 


Key Benefits

  • The report provides detailed analysis about the driving and limiting factors of the Bioinformatics market, which would give a deeper understanding of the subject and help in analyzing the various applications of bioinformatics 
  • The application market helps in analyzing the various application segments, thus helping the stakeholders understand opportunities in the various fields of bioinformatics market 
  • To understand the bioinformatics market and its segments and to gain a deeper understanding of trends adopted
  • The report analyzes the market conditions in a comprehensive and quantitative manner and forecast market trends and techniques used in bioinformatics
  • The market is forecast in terms of revenue throughout 2013 to 2020.

Key Deliverables

The global Bioinformatics market is segmented based on technology & services, application, sector and geography.

BY TECHNOLOGY AND SERVICES

  • Knowledge Management Tools
    • Generalized knowledge management tools
    • Specialized knowledge management tools
  • Bioinformatics Platforms 
    • Sequence analysis platforms
    • Sequence alignment platforms
    • Sequence manipulation platforms
    • Structural analysis platforms
    • Others
  • Bioinformatics Services
    • Sequencing services
    • Database and management
    • Data Analysis
    • Others

BY APPLICATION

  • Metabolomics
  • Molecular Phylogenetics
  • Transcriptomics
  • Proteomics
  • Chemoinformatics
  • Genomics
  • Others

BY SECTOR

  • Medical Bioinformatics
  • Animal Bioinformatics
  • Agriculture Bioinformatics
  • Academics 
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • RoW

CHAPTER 1. INTRODUCTION

1.1 Report Description
1.2 Key Market Segments
1.3 Key benefits
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. BIOINFORMATICS MARKET OVERVIEW

3.1 Market definition and scope
3.2 Introduction

3.2.1 Components
3.2.2 Biological Databases
3.2.3 Applications of bioinformatics

3.3 Trends and challenges faced by the industry
3.4 Bioinformatics – cloud services
3.5 Next-generation sequencing services
3.6 Value chain analysis - bioinformatics and drug development
3.7 Bioinformatics in the drug development process
3.8 Patent analysis
3.9 Key findings

3.9.1 Top ten factors impacting Bioinformatics market
3.9.2 Top winning strategies in the Bioinformatics market
3.9.3 Top investment pockets in Bioinformatics market

3.9.3.1 Top investment markets by application
3.9.3.2 Top investment markets by sector

3.10 Porter’s five-forces analysis

3.10.1 Bargaining power of suppliers is low
3.10.2 Bargaining power of the buyer is high
 3.10.3 Threats for new entrants
3.10.4 High competition
3.10.5 Threat from substitutes

3.11 Case study: Supercomputing Cluster
3.12 Regulations
3.13 Market dynamics

3.13.1 Drivers

3.13.1.1 Need for integrated data
3.13.1.2 Increasing growth in proteomics and genomics
3.13.1.3 Drug discovery and development
3.13.1.4 Government initiatives

3.13.2 Restraints

3.13.2.1 Need for skilled PERSONNEL
3.13.2.2 Common data formats
3.13.2.3 Pharmaceutical sector saturation

3.13.3 Opportunities

3.13.3.1 Standardization
3.13.3.2 Need for integrated solutions and systems
3.13.3.3 Data overload

CHAPTER 4. GLOBAL BIOINFORMATICS MARKET BY TECHNOLOGY AND SERVICES

4.1 Global bioinformatics market by technology, platforms and services
4.2 Bioinformatics Content/Knowledge Management Tools

4.2.1 Global bioinformatics knowledge management tools market by type
4.2.2 Bioinformatics knowledge management tools market by geography
4.2.3 Generalized knowledge management tools

4.2.3.1    Bioinformatics Generalized Knowledge Management Tools market by geography

4.2.4 Specialized knowledge management

4.2.4.1    Bioinformatics Specialized Knowledge Management Tools market by geography

4.3 Bioinformatics Platforms

4.3.1 Global bioinformatics platforms market by type
4.3.2 Bioinformatics platforms market by geography
4.3.3 Sequence Analysis Platforms

4.3.3.1    Bioinformatics Sequence Analysis platform market by geography

4.3.4 Sequence alignment platforms

4.3.4.1    Bioinformatics Sequence alignment platform market by geography

4.3.5 Sequence Manipulation Platforms

4.3.5.1    Bioinformatics Sequence Manipulation platform market by geography

4.3.6 Structural Analysis Platforms

4.3.6.1    Bioinformatics Structural Analysis platform market by geography

4.3.7 Other Platforms

4.3.7.1    Bioinformatics others platform market by geography

4.4 Bioinformatics services

4.4.1 Global bioinformatics service market
4.4.2 Bioinformatics services market by geography
4.4.3 Sequencing Services

4.4.3.1    Bioinformatics Sequencing Services market by geography

4.4.4 Database and Management

4.4.4.1    Bioinformatics database &management Services market by geography

4.4.5 Data Analysis

4.4.5.1    Bioinformatics data analysis Services market by geography

4.4.6 Others (Data services) market

4.4.6.1    Bioinformatics other Services market by geography

CHAPTER 5. GLOBAL BIOINFORMATICS MARKET BY APPLICATION

5.1 Global bioinformatics application market
5.2 Genomics

5.2.1 Bioinformatics genomics application market by geography

5.3 Chemoinformatics and Drug Design

5.3.1 Bioinformatics chemoinformatics and drug design application market by geography

5.4 Proteomics

5.4.1 Bioinformatics Proteomics application market by geography

5.5 Transcriptomics

5.5.1 Bioinformatics Transcriptomics application market by geography

5.6 Metabolomics 

5.6.1 Bioinformatics Metabolomics application market by geography

5.7 Molecular Phylogenetics

5.7.1 Bioinformatics Molecular Phylogenetics application market by geography

5.8 Other application market

5.8.1 Pharmacogenomics
5.8.2 Pharmacoproteomics
5.8.3 Bioinformatics other application market by geography

CHAPTER 6. GLOBAL BIOINFORMATICS MARKET BY SECTOR

6.1 Global Bioinformatics market by sector
6.2 Medical bioinformatics

6.2.1 Drug development
6.2.2 Molecular medicine
6.2.3 Preventive medicine
6.2.4 Gene therapy
6.2.5 Medical Bioinformatics sector market by geography

6.3 Animal Bioinformatics

6.3.1 Animal Bioinformatics sector market by geography

6.4 Agricultural bioinformatics

6.4.1 Crop yield improvement
6.4.2 Pest resistance
6.4.3 Plant resistance against abiotic stresses
6.4.4 Improve nutritional quality
6.4.5 Agriculture bioinformatics sector market by geography

6.5 Academics

6.5.1 Global Bioinformatics Academics sector market by geography

6.6 Others (Microbial genome)

6.6.1 Bioinformatics other sectors market by geography

CHAPTER 7. GLOBAL BIOINFORMATICS MARKET BY GEOGRAPHY

7.1 North America

7.1.1 North America bioinformatics market

7.2 Europe

7.2.1 Europe bioinformatics market

7.3 Asia pacific

7.3.1 Asia Pacific bioinformatics market

7.4 RoW

7.4.1 RoW bioinformatics market

CHAPTER 8. COMPANY PROFILES

8.1 Accelrys, Inc.

8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Business performance
8.1.4 Strategic moves and developments
8.1.5 SWOT Analysis of Accelrys, Inc

8.2 Affymetrix, Inc.

8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Business performance
8.2.4 Strategic moves and developments
8.2.5 SWOT Analysis of Affymetrix, Inc

8.3 Agilent Technologies, Inc.

8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Business performance
8.3.4 Strategic moves and developments
8.3.5 SWOT Analysis of Agilent technologies, Inc

8.4 Geneva Bioinformatics (Genebio) SA

8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Strategic moves and developments
8.4.4 SWOT Analysis of Geneva Bioinformatics (GeneBio) SA

8.5 Nonlinear Dynamics

8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Strategic moves and developments
8.5.4 SWOT Analysis of Nonlinear Dynamics Ltd.

8.6 Quest Diagnostics, Inc.

8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Business performance
8.6.4 Strategic moves and developments

8.6.4.1 Primary Strategies
8.6.4.2    Secondary Strategies

8.6.5 SWOT Analysis of Quest Diagnostics

8.7 Illumina

8.7.1 Company overview 
8.7.2 Company snapshot
8.7.3 Business performance
8.7.4 Strategic moves and developments

8.7.4.1    Primary Strategies
8.7.4.2    Secondary Strategies

8.7.5 SWOT Analysis of Illumina, Inc.

8.8 Bruker Daltonics Inc

8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Business performance
8.8.4 Strategic moves and developments

8.8.4.1    Primary Strategies

8.8.5 SWOT Analysis of Bruker Daltonics, Inc.

8.9 Biomax Informatics AG

8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Strategic moves and developments

8.9.3.1    Primary Strategies
8.9.3.2    Secondary Strategies

8.9.4 SWOT Analysis of Biomax Informatics AG

8.10 Life Technologies Corporation 

8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Business performance
8.10.4 Strategic moves and developments

8.10.4.1 Primary Strategies
8.10.4.2 Secondary Strategies

8.10.5 SWOT Analysis of Life technologies 

 

LIST OF TABLES

TABLE 1  BIOINFORMATICS MARKET BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 2  LIST OF PATENT
TABLE 3  GLOBAL BIOINFORMATICS MARKET BY TECHNOLOGY, PLATFORMS AND SERVICES, 2013-2020($MILLION)
TABLE 4  GLOBAL BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET BY TYPE, 2013-2020 ($MILLION)
TABLE 5  BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 6  BIOINFORMATICS GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 7  BIOINFORMATICS SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 8  GLOBAL BIOINFORMATICS MARKET, BY PLATFORMS
TABLE 9  BIOINFORMATICS PLATFORMS MARKET BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 10 BIOINFORMATICS SEQUENCE ANALYSIS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 11 BIOINFORMATICS SEQUENCE ALIGNMENT PLATFORM MARKET, BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 12 BIOINFORMATICS SEQUENCE MANIPULATION PLATFORM MARKET, BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 13 BIOINFORMATICS STRUCTURAL ANALYSIS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 14 BIOINFORMATICS OTHERS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 15 GLOBAL BIOINFORMATICS MARKET, BY SERVICES 2013-2020 ($MILLION)
TABLE 16 BIOINFORMATICS SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 17 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 18 BIOINFORMATICS DATABASE &MANAGEMENT SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 19 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 20 BIOINFORMATICS OTHER SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 21 GLOBAL BIOINFORMATICS MARKET, BY APPLICATION 2013-2020($MILLION)
TABLE 22 BIOINFORMATICS GENOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 23 BIOINFORMATICS CHEMOINFORMATICS AND DRUG DESIGN APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 24 BIOINFORMATICS PROTEOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 25 BIOINFORMATICS TRANSCRIPTOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 26 BIOINFORMATICS METABOLOMICS APPLICATION MARKET, BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 27 BIOINFORMATICS MOLECULAR PHYLOGENETICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 28 BIOINFORMATICS OTHER APPLICATION MARKET, BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 29 GLOBAL BIOINFORMATICS MARKET BY SECTOR, 2013-2020($MILLION)
TABLE 30 MEDICAL BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 31 ANIMAL BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 32 AGRICULTURE BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013 – 2020 ($MILLION)
TABLE 33 GLOBAL BIOINFORMATICS ACADEMICS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 34 BIOINFORMATICS OTHERS SECTORS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 35 NORTH AMERICAN BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 36 EUROPE BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 37 ASIA PACIFIC BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 38 ROW BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 39 ACCELRYS, INC BUSINESS SNAPSHOT
TABLE 40 AFFYMETRIX, INC. BUSINESS SNAPSHOT
TABLE 41 AGILENT TECHNOLOGIES, INC BUSINESS SNAPSHOT
TABLE 42 GENEVA BIOINFORMATICS (GENEBIO) SA BUSINESS SNAPSHOT
TABLE 43 NONLINEAR DYNAMICS LTD. BUSINESS SNAPSHOT
TABLE 44 QUEST DIAGNOSTICS BUSINESS SNAPSHOT
TABLE 45 ILLUMINA, INC. BUSINESS SNAPSHOT
TABLE 46 BRUKER DALTONICS, INC. BUSINESS SNAPSHOT
TABLE 47 BIOMAX INFORMATICS AG BUSINESS SNAPSHOT
TABLE 48 LIFE TECHNOLOGIES BUSINESS SNAPSHOT

 

LIST OF FIGURES

FIG. 1 VALUE CHAIN ANALYSIS
FIG. 2 COMPARATIVE ANALYSIS OF APPLICATION MARKET
FIG. 3 PATENT REGISTERED IN THE U.S., EUROPE AND JAPAN
FIG. 4 TOP FACTORS IMPACTING IVD MARKET (2013-2020)
FIG. 5 TOP WINNING STRATEGIES
FIG. 6 TOP INVESTMENT MARKET BY APPLICATIONS
FIG. 7 TOP INVESTMENT MARKETS BY SECTOR
FIG. 8 PORTER’S FIVE FORCE ANALYSIS
FIG. 9 TYPES OF GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
FIG. 10 TYPES OF SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
FIG. 11 TYPES OF SEQUENCE ANALYSIS PLATFORMS
FIG. 12 TYPES OF STRUCTURAL ANALYSIS PLATFORMS
FIG. 13 STEPS IN DATABASE & MANAGEMENT
FIG. 14 GENOMIC APPLICATIONS BASED ON CLINICAL FIELDS (2012)
FIG. 15 GEOGRAPHIC LOCATION OF NEXT GENERATION SEQUENCING (NGS) SUPPLIERS USED IN GENOMICS
FIG. 16 CHEMOINFORMATICS WORKFLOW
FIG. 17 ROLE OF CHEMOINFORMATICS IN DRUG DISCOVERY
FIG. 18 ROLE OF TRANSCRIPTOMICS IN DRUG DISCOVERY
FIG. 19 ROLE OF METABOLOMICS IN DIAGNOSTICS
FIG. 20 ANALYSIS OF METABOLOMICS DATA
FIG. 21 PHYLOGENETIC FOUR STEP ANALYSIS
FIG. 22 FARM ANIMAL GENOMICS
FIG. 23 CHALLENGES FACED BY BIOINFORMATICS IN ASIA PACIFIC REGION
FIG. 24 TOTAL REVENUE BY GEOGRAPHY
FIG. 25 SWOT ANALYSIS OF ACCELRYS, INC.
FIG. 26 TOTAL REVENUE BY GEOGRAPHY
FIG. 27 TOTAL REVENUE BY BUSINESS UNIT
FIG. 28 SWOT ANALYSIS OF AFFYMETRIX, INC.
FIG. 29 AGILENT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
FIG. 30 AGILENT TECHNOLOGIES - REVENUE MIX BY GEOGRAPHY (2013)
FIG. 31 KEYSIGHT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
FIG. 32 KEYSIGHT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
FIG. 33 SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC
FIG. 34 SWOT ANALYSIS OF GENEVA BIOINFORMATICS (GENEBIO) SA
FIG. 35 SWOT ANALYSIS OF NONLINEAR DYNAMICS LTD.
FIG. 36 PERCENTAGE OF REVENUE GENERATION BY BUSINESS UNITS
FIG. 37 SWOT ANALYSIS OF QUEST DIAGNOSTICS
FIG. 38 SWOT ANALYSIS OF ILLUMINA, INC.
FIG. 39 SWOT ANALYSIS OF BRUKER DALTONICS, INC.
FIG. 40 SWOT ANALYSIS OF BIOMAX INFORMATICS AG
FIG. 41 FINANCIAL REVENUES BY END MARKETS (2012)
FIG. 42 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 43 SWOT ANALYSIS OF LIFE TECHNOLOGIE

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Bioinformatics is a combination of molecular biology with computer science and is essential to storing genetic information for understanding (identifying can be used) human diseases and for further identification of molecular targets for discovering drugs. The bioinformatics is utilized in various fields such as statistics, computer science, engineering and mathematics involved in studying and processing of biological data. Bioinformatics helps in the development of software tools and methods for organizing, analyzing, retrieving and storing biological data and genetic information, all of which have varied applications in the field of  drug discovery and drug development, based on genetic information.

The tremendous application of bioinformatics forms a major part of almost all biological fields such as animal breeding, agriculture, preventive medicines, molecular medicine and various other uses. The Bioinformatics market is increasing due to growing demand in drug discovery & development and the increasing need for integrated data. Moreover, many researchers are focusing on prospective fields like proteomics and genomics R&D in these fields significantly augment the growth of the global bioinformatics market. Additionally, government authorities are taking initiatives for the standardization and management of overloaded data due to the frequent experiments conducted in various fields of medical science. However,  complex methods used in bioinformatics-related tools and the impending need for exceptionally skilled individuals is limiting the growth for the same. Nevertheless, decreased cost of genetic sequencing, owing  to the discovery of novel technologies and software tools along with the advancements  in the genomic field are responsible for augmenting the growth of this market. Other fruitful applications of bioinformatics include outsourcing of services for effective support to R&D activities at lower cost. 

SIMILAR MARKET STUDIES

Published Reports

Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells.
30 Jun 2014 | Price: $4515(SU) | View Details >>

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. It is also used for clinical diagnostic confirmation and in prenatal diagnostics.
27 Aug 2014 | Price: $4515(SU) | View Details >>

Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
27 May 2014 | Price: $4515(SU) | View Details >>

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market.
10 Jun 2014 | Price: $4515(SU) | View Details >>

Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include - Adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies.
21 Jan 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.
Price: $4515 | Pre Book Price: $4515 | View Details >>

The label free detection method is used for detecting biomolecules and their interactions. This method has emerged as an attractive research and development tool in the pharmaceutical and biotech industry.
Price: $4515 | Pre Book Price: $4515 | View Details >>

DNA sequencing is a process used to determine the order of nucleotides within DNA molecules. Prenatal DNA sequencing is the method of sequencing the DNA isolated from pregnant women’s blood to reveal the full genetic code of a fetus. Prenatal DNA sequencing is used to sequence the whole genome of unborn baby that effectively detects the diseases
Price: $4515 | Pre Book Price: $4515 | View Details >>

Identification documents and PIN are traditional methods used to verify the identity of a human being. However, an increasing number of cases of security threats, illegal transactions at ATMs, unauthorised immigration and unauthorised infiltration across borders are factors which have resulted in the evolution of new generation biometrics methods. New generation biometrics refers to technologies that are used to verify the identity of individuals through biological characteristics such as facial expression, voice, palm, fingerprints, signature, iris, vein and DNA.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Tissue engineering is the combination of biology medicine and engineering to create products that would improve or replace biological functions or organs. More than a decade ago, the industry introduced the first FDA approved tissue-engineering product, which was a skin substitute product. These products provide natural regeneration of tissues or cells, and hence are highly effective. The medical biotechnology industry was estimated to be $160 billion in 2012.The major drivers in this industry are chronic wound and orthopedic application segment.
Price: $4515 | Pre Book Price: $4515 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Get Discount

NEED MORE INFORMATION?
Call
+1 617 674 4143


Purchase Enquiry

PURCHASE OPTIONS

Single User
By obtaining a Single User License, you and your organization concur that only an individual uses this report either electronically or online. The right to use or stockpiling of the report should be confined only to one authorized computer. User will have authorization to print one duplicate of the report for individual use, yet may not be replicated for circulation. Additional copies for this report may also be order at discounted price for use by addition readers/users.
$4515

Multi User 
Multi-User license permits you to access the report from eight authorized computers. It does not permit you to display it on your company website and permits you to only print 5 copies of the report that shall not be reproduced for circulation.
$7515

Corporate  
With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report in is prohibited without the prior permission of Allied Market Research. The publisher will, in turn, regard the privacy of the purchaser and will keep it confidential. Upon buying single or multi-user license, buyer must provide the names and email ids of the authorized users of this report.
$10515


Not Interested in buying complete report?
To check the cost of chapters
WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader







Top